Life Science Industry Coalition Position paper

14 December 2017

Policy

Position Paper: for an ambitious EU industrial strategy

24 October 2017

Policy

SPC manufacturing waiver

24 October 2017

Policy

SME Intergroup Conclusions – Boosting SMEs through the SPC Waiver […]

Fighting counterfeit medicines in Europe: the effect on access to medicines

14 September 2017

Policy

The implementation of the Falsified Medicines Directive, and its Delegated […]

US FDA Advisory committee hears first-hand about the decade of EU experience with biosimilar medicines use

13 July 2017

Policy

Medicines for Europe Director General Adrian van de Hoven participated […]

Medicines for Europe Country Specific Market Access Policies

23 May 2017

Policy